A healthcare proposal circulated by the White House in recent days is running into the reality of Republican divisions on the ...

In a proof-of-concept, placebo-controlled trial, the investigational oral selective AKT inhibitor engasertib appeared to be ...

Over time, drivers with mild cognitive impairment showed greater reductions in monthly trip counts, nightly trips, and ...

Supporters of Make America Healthy Again (MAHA) say the movement is improving the U.S. food supply and fighting corruption ...

Adults prescribed a GLP-1 agent had a 12% higher risk for developing a new chronic cough -- one that persists for over 8 ...

FDA chief Mary Makary, MD, MPH, and his boss HHS Secretary Robert F. Kennedy Jr. are locked in a power struggle over vaccine ...

The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...

The FDA approved perioperative durvalumab (Imfinzi) in combination with a multidrug chemotherapy regimen for resectable ...

Tests of ByHeart infant formula tied to a botulism outbreak that has sickened dozens of babies showed that all of the company ...

Sibeprenlimab, a monoclonal antibody, is the only IgA nephropathy treatment option to selectively inhibit the activity of a ...

In this MedPage Today video, Sayna Norouzi, MD, of the Loma Linda University Medical Center in California, offers practical ...